Table of Contents

|Articles|January 1, 2004

Pharmaceutical Executive

Pharmaceutical Executive-01-01-2004

Table of Contents

External Link - article-80918.pdf

Articles in this issue

over 22 years ago

Article

PE's Annual Sales and Marketing Employment Survey: The Big Squeeze

over 22 years ago

Article

Streamlining For Success with Fred Price of BioMarin

over 22 years ago

Article

The Making of a New Disease

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Articles in this issue

Related Content

Pharmaceutical Executive Daily: TrumpRx Expands to Offer Over 600 Generic Drugs

Inside the Expert Network Guiding TGN-S15 to Market

TrumpRx Expands to Offer Generic Medications

Rethinking Pharma's Go-to-Market Formula

Pharma Funding Roundup: Violet Therapeutics' $4.75 Million Seed Extension Financing, Full-Life Technologies Completes $150 Million Financing

Trending on PharmExec

FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report

Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates

The Risks and Benefits of FDA Reviewing Real-Time Data

FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry

Pharmaceutical Executive Daily: FDA Approves Baxdrostat